Key terms

About OGN

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest OGN news

May 03 3:25am ET Goldman Sachs Sticks to Their Hold Rating for Organon (OGN) by TipRanks May 02 8:28am ET Organon sees FY24 revenue $6.2B – $6.5B, consensus $6.37B by TipRanks May 02 8:25am ET Organon reports Q1 EPS $1.22, consensus 93c by TipRanks May 02 7:52am ET Organon Q1 2024 Financial Results Presentation Update by TipRanks May 01 3:50am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Legend Biotech (LEGN), Organon (OGN) and Exelixis (EXEL) by TipRanks Apr 29 6:46am ET Organon price target raised to $24 from $22 at Piper Sandler by TipRanks Apr 23 5:59am ET Barclays Sticks to Their Buy Rating for Organon (OGN) by TipRanks Apr 19 1:45am ET Organon’s Steady Market Position Maintains Neutral Rating Amidst Conservative Revenue Forecasts by TipRanks Apr 08 6:09am ET Organon, Shanghai Henlius Biotech: Phase 3 study of HLX14 met primary endpoints by TipRanks Feb 27 1:01am ET Organon & Co. Is Worried About This – Should You Be Worried Too? by TipRanks Feb 16 9:20am ET Analysts Offer Insights on Healthcare Companies: Organon (OGN) and Sarepta Therapeutics (SRPT) by TipRanks Feb 16 7:38am ET Piper Sandler Remains a Buy on Organon (OGN) by TipRanks Feb 16 5:31am ET Organon price target raised to $26 from $25 at Barclays by TipRanks Feb 16 5:21am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Sanofi (OtherSNYNF), Laboratory (LH) and Organon (OGN) by TipRanks Feb 16 5:11am ET Maintaining Sell Rating on Organon: Short-Term Gains Overshadowed by Long-Term Strategy Concerns by TipRanks Feb 15 8:02am ET Organon Reports Quarterly and Annual Financial Results by TipRanks Feb 15 7:38am ET Organon sees FY24 revenue $6.2B-$6.5B, consensus $6.41B by TipRanks Feb 15 7:36am ET Organon reports Q4 adjusted EPS 88c, consensus 83c by TipRanks

No recent press releases are available for OGN

OGN Financials

1-year income & revenue

Key terms

OGN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

OGN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - MAY 03: Traders work on the floor of the New York Stock Exchange (NYSE) on May 03, 2024 in New York City. The Dow surged over 400 points in morning trading as new economic numbers showed that the central bank may cut interest rates sooner than expected. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images North America/Getty Images
There’s a surprising bit of good news lurking in the stock market
Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse